For more classes visit
www.snaptutorial.com
Discussion Part One
Emily, a relatively healthy 5’5”, 32-year-old young woman weighing 190 pounds, presents to your clinic with hirsutism, anovulation, oligomenorrhea, and at times amenorrhea. Biochemical blood tests reveal elevated luteinizing hormone (LH, without a mid-cycle surge) and androgen elevation.
Nr 508 Education Organization / snaptutorial.comBaileya135
For more classes visit
www.snaptutorial.com
Discussion Part One
Emily, a relatively healthy 5’5”, 32-year-old young woman weighing 190 pounds, presents to your clinic with hirsutism, anovulation, oligomenorrhea, and at times amenorrhea. Biochemical blood tests reveal elevated luteinizing hormone (LH, without a mid-cycle surge) and androgen elevation.
NR 508 Education Specialist / snaptutorial.comMcdonaldRyan149
This document discusses the case of a patient named Adam who presents with respiratory symptoms including wheezing, dyspnea, cough and sputum production, especially during exercise. The assistant provides a diagnosis, pharmacological treatment plan and monitoring recommendations over three discussions. In discussion two, it is revealed the patient is also taking metoprolol which could be exacerbating his symptoms due to its mechanism of action. The assistant modifies the treatment plan and discusses monitoring.
Nr 508 Education Redefined-snaptutorial.comrobertledwes48
For more classes visit
www.snaptutorial.com
Discussion Part One
Emily, a relatively healthy 5’5”, 32-year-old young woman weighing 190 pounds, presents to your clinic with hirsutism, anovulation, oligomenorrhea, and at times amenorrhea. Biochemical blood tests reveal elevated luteinizing hormone (LH, without a mid-cycle surge) and androgen elevation.
Nr 508 Education Organization -- snaptutorial.comDavisMurphyC7
For more classes visit
www.snaptutorial.com
Discussion Part One
Emily, a relatively healthy 5’5”, 32-year-old young woman weighing 190 pounds, presents to your clinic with hirsutism, anovulation, oligomenorrhea, and at times amenorrhea. Biochemical blood tests reveal elevated
NR 508 Effective Communication - tutorialrank.comBartholomew49
For more course tutorials visit
www.tutorialrank.com
Discussion Part One
Emily, a relatively healthy 5’5”, 32-year-old young woman weighing 190 pounds, presents to your clinic with hirsutism, anovulation, oligomenorrhea, and at times amenorrhea. Biochemical blood tests reveal elevated luteinizing hormone (LH, without a mid-cycle surge) and androgen elevation.
NR 508 Inspiring Innovation/tutorialrank.comjonhson143
For more course tutorials visit
www.tutorialrank.com
Discussion Part One
Emily, a relatively healthy 5’5”, 32-year-old young woman weighing 190 pounds, presents to your clinic with hirsutism, anovulation, oligomenorrhea, and at times amenorrhea. Biochemical blood tests reveal elevated luteinizing hormone (LH, without a mid-cycle surge) and androgen elevation.
The document discusses the use of herbal treatments for epilepsy. It notes that while some herbal remedies have been used for centuries to treat seizures, the evidence for their efficacy is limited and mixed. Many herbs can interact with antiepileptic drugs in ways that increase side effects or decrease drug levels. The document cautions that while some individuals may benefit, herbs could worsen seizures for others or have other health risks that outweigh potential benefits for most epilepsy patients. Open communication between doctors and patients about herbal use is important.
1) The document describes two clinical cases where quetiapine was used. Case 1 involved a 56-year-old man with severe depression without psychosis, who showed improved motivation and functioning after starting quetiapine along with other medications.
2) Case 2 involved a 33-year-old woman with traits of borderline personality disorder and adjustment issues. She took her husband's quetiapine on occasion when feeling emotionally unstable and found it helped reduce her symptoms.
3) The document discusses how quetiapine's action on dopamine, serotonin, norepinephrine, glutamate and GABA systems may help explain its efficacy as an antidepressant when added to other antidepressants for conditions like major
Nr 508 Education Organization / snaptutorial.comBaileya135
For more classes visit
www.snaptutorial.com
Discussion Part One
Emily, a relatively healthy 5’5”, 32-year-old young woman weighing 190 pounds, presents to your clinic with hirsutism, anovulation, oligomenorrhea, and at times amenorrhea. Biochemical blood tests reveal elevated luteinizing hormone (LH, without a mid-cycle surge) and androgen elevation.
NR 508 Education Specialist / snaptutorial.comMcdonaldRyan149
This document discusses the case of a patient named Adam who presents with respiratory symptoms including wheezing, dyspnea, cough and sputum production, especially during exercise. The assistant provides a diagnosis, pharmacological treatment plan and monitoring recommendations over three discussions. In discussion two, it is revealed the patient is also taking metoprolol which could be exacerbating his symptoms due to its mechanism of action. The assistant modifies the treatment plan and discusses monitoring.
Nr 508 Education Redefined-snaptutorial.comrobertledwes48
For more classes visit
www.snaptutorial.com
Discussion Part One
Emily, a relatively healthy 5’5”, 32-year-old young woman weighing 190 pounds, presents to your clinic with hirsutism, anovulation, oligomenorrhea, and at times amenorrhea. Biochemical blood tests reveal elevated luteinizing hormone (LH, without a mid-cycle surge) and androgen elevation.
Nr 508 Education Organization -- snaptutorial.comDavisMurphyC7
For more classes visit
www.snaptutorial.com
Discussion Part One
Emily, a relatively healthy 5’5”, 32-year-old young woman weighing 190 pounds, presents to your clinic with hirsutism, anovulation, oligomenorrhea, and at times amenorrhea. Biochemical blood tests reveal elevated
NR 508 Effective Communication - tutorialrank.comBartholomew49
For more course tutorials visit
www.tutorialrank.com
Discussion Part One
Emily, a relatively healthy 5’5”, 32-year-old young woman weighing 190 pounds, presents to your clinic with hirsutism, anovulation, oligomenorrhea, and at times amenorrhea. Biochemical blood tests reveal elevated luteinizing hormone (LH, without a mid-cycle surge) and androgen elevation.
NR 508 Inspiring Innovation/tutorialrank.comjonhson143
For more course tutorials visit
www.tutorialrank.com
Discussion Part One
Emily, a relatively healthy 5’5”, 32-year-old young woman weighing 190 pounds, presents to your clinic with hirsutism, anovulation, oligomenorrhea, and at times amenorrhea. Biochemical blood tests reveal elevated luteinizing hormone (LH, without a mid-cycle surge) and androgen elevation.
The document discusses the use of herbal treatments for epilepsy. It notes that while some herbal remedies have been used for centuries to treat seizures, the evidence for their efficacy is limited and mixed. Many herbs can interact with antiepileptic drugs in ways that increase side effects or decrease drug levels. The document cautions that while some individuals may benefit, herbs could worsen seizures for others or have other health risks that outweigh potential benefits for most epilepsy patients. Open communication between doctors and patients about herbal use is important.
1) The document describes two clinical cases where quetiapine was used. Case 1 involved a 56-year-old man with severe depression without psychosis, who showed improved motivation and functioning after starting quetiapine along with other medications.
2) Case 2 involved a 33-year-old woman with traits of borderline personality disorder and adjustment issues. She took her husband's quetiapine on occasion when feeling emotionally unstable and found it helped reduce her symptoms.
3) The document discusses how quetiapine's action on dopamine, serotonin, norepinephrine, glutamate and GABA systems may help explain its efficacy as an antidepressant when added to other antidepressants for conditions like major
The document discusses various methods of administering medical cannabis for cancer patients including inhalation, ingestion, and topical application. It notes the time of onset and duration of effects for each method. The document also provides an overview of the endocannabinoid system and how cannabis may help certain cancer symptoms like pain, appetite issues, and nausea. It outlines some promising areas of preclinical research on cannabinoids treating different types of cancer. Potential side effects of cannabis are also mentioned.
This document provides guidance on deprescribing benzodiazepine receptor agonists (BZRAs) used to treat insomnia. It recommends non-drug approaches like cognitive behavioral therapy (CBT) as first-line treatment for insomnia. For patients taking BZRAs, it outlines a gradual tapering process to minimize withdrawal symptoms. Tapering should be individualized and involve both patient education and behavioral strategies to manage insomnia without medications.
This document discusses two case studies about prescribing analgesics for pain management.
In the first case study, a 35-year old man had hemorrhoid surgery and was initially prescribed paracetamol and celecoxib, but still reported a pain score of 7/10 after 4 hours.
The second case study describes an 81-year old woman with hip fracture reporting an 8/10 pain score. She has various medical conditions including hypertension, coronary artery disease, and diabetes.
The document prompts the reader to consider what additional analgesics they would prescribe for each case, taking into account factors like the patients' medical histories and reported pain levels.
The document discusses 10 medical conditions that may be helped by cannabis: epilepsy, chronic pain, fibromyalgia, post-traumatic stress disorder, multiple sclerosis, migraines, Crohn's disease, glaucoma/iritis, cancer, and Parkinson's disease. For each condition, it provides brief examples or studies that indicate cannabis may effectively treat symptoms, reduce pain, lower seizure activity, combat nausea, and more. The conclusion urges readers to share the information and advocate for legalizing medical cannabis.
This document summarizes the clinical uses of the antipsychotic drug quetiapine. It discusses quetiapine's approval for treating schizophrenia, bipolar disorder, depression, and other off-label uses. Key points include quetiapine being the first-line treatment for bipolar depression, its efficacy in reducing symptoms of schizophrenia and mania, and dosage guidelines for different conditions. Recent studies are cited showing quetiapine's benefits for outcomes in schizophrenia and improvements in working memory compared to other antipsychotics.
Quetiapine (brand name Seroquel) is an antipsychotic medication used to treat schizophrenia, bipolar disorder, depression, and other mental health conditions. It works by affecting dopamine and serotonin levels in the brain. Generic versions have been found to be equivalent to the brand name when rated by the FDA. Common side effects include drowsiness, dizziness, and dry mouth. It is important to take quetiapine as prescribed by your doctor and notify them immediately of any severe side effects. Community support workers should follow care plans, monitor for side effects, and ensure clients stay hydrated when taking quetiapine.
This document provides a guide for managing common symptoms in seriously ill pediatric patients, with a focus on end-of-life care. It outlines the social and medical aspects of accepting palliative care over curative treatment, maintaining comfort through active medical care, and managing a home or hospital death. The document also provides guidance on treating pain, nausea, anxiety, and other symptoms through pharmacological and non-pharmacological means.
This document provides an overview of managing pain in patients with or at risk for substance use disorders. It discusses the overlap between chronic pain and addiction, differentiating between types of pain and substance use disorders. It outlines goals of treatment as reducing suffering while eliminating unnecessary medication dependence. The document provides guidance on assessing patients' risk level and appropriately selecting and monitoring pain medications, with an emphasis on non-opioid options for high-risk patients. It also stresses the importance of addressing underlying mental health and social factors contributing to a patient's pain and addiction.
Premenstrual Syndrome – Recent Guidelines
Premenstrual Syndrome & Premenstrual Dysphoric Disorder
Incidence
80% of women have atleast one physical or psychiatric symptom during luteal phase
PMS -12-15%
PMDD – 1.3-5.3%
Quetiapine is a first-line atypical antipsychotic that has been used since 1998 for schizophrenia, bipolar disorder, depression, and other conditions. It is absorbed quickly in the body and metabolized in the liver. Quetiapine acts as an antagonist at serotonin, histamine, alpha-1, and dopamine receptors, with varying degrees of affinity. Common side effects include sedation, dizziness, hypotension, weight gain, and metabolic changes. Overdoses may cause lethargy, tachycardia, respiratory issues, and other symptoms, but are typically not fatal.
Second generation atypical anti-psychotic used for mental disorders more extensively for bipolar disorder. have very low side effects than other SGA Medications
Benefits of marijuana cannabis to chemotherapy (thesis)Daniel Bragais
This document discusses the benefits of marijuana for chemotherapy patients. It provides background on marijuana and its properties. Key points include:
- Marijuana contains THC which can help reduce nausea and vomiting from chemotherapy as well as ease other side effects.
- A case study is described of a woman named Leela whose health improved dramatically after being treated with cannabis oil for her cancer.
- The interviewee believes legalizing and regulating marijuana could help many cancer patients and create new jobs. However, some doctors remain skeptical due to cognitive biases and existing beliefs about pharmaceutical treatments.
Quetiapine in Clinical Neurological PracticeDr Tarek Asaad
Quetiapine XR provides advantages over the immediate release formulation for patients and clinicians. It allows for once-daily dosing, simplifies titration, and facilitates reaching therapeutic doses earlier through an initial higher dose. This makes adherence more likely. Studies also found Quetiapine XR had a better tolerability profile with less sedation and orthostatic hypotension compared to the immediate release formulation. Quetiapine more broadly has benefits for treating depression, psychosis, and behavioral symptoms associated with various neurological conditions due its antidepressant, antipsychotic, and sleep promoting effects with a low risk of side effects.
Generic Quetiapine Fumarate tablets (Qutipin) contain the active ingredient Quetiapine Fumarate. They are used to treat schizophrenia and bipolar disorder. They are manufactured by Sun Pharmaceutical Industries Ltd. and are available in strengths of 25 mg, 50 mg, 100 mg, 200 mg, and 300 mg. Qutipin is used for the treatment of schizophrenia as well as acute manic episodes and maintenance treatment of bipolar I disorder.
Premenstrual syndrome, or PMS, is a group of symptoms that start one to two weeks before your period. Most women have at least some symptoms of PMS, and the symptoms go away after their periods start. For some women, the symptoms are severe enough to interfere with their lives. They have a type of PMS called premenstrual dysphoric disorder, or PMDD.
Cannabis in India - HempCann owns the brand VEDI and is Manufacturer and Marketer of an excellent quality array of Ayurvedic, Herbals, Cannabis Medicine & Cannabis Oil and Castile Soap - Once you use a VEDI castile soap, no other soap will do.
https://vediherbals.com/
Cannabis in India - HempCann owns the brand VEDI and is Manufacturer and Marketer of an excellent quality array of Ayurvedic, Herbals, Cannabis Medicine & Cannabis Oil and Castile Soap - Once you use a VEDI castile soap, no other soap will do. https://vediherbals.com/
Crimson Publishers- Protecting Embryo with Chinese Herbal Medicine for Treati...CrimsonPublishers-PRM
It is almost impossible to protect the embryo, ladies successfully complete pregnancy, and have healthy babies, if they are going through vaginal bleeding, abdominal cramp and showing some other signs at the early month of pregnancy, which will normally end in miscarriages before TCM enters the West. Since the beginning of my practice of TCM (Acupuncture and Chinese herbal medicine) in UK, I have been using TCM for protecting embryo and terminating signs of miscarriage effectively in order to help ladies naturally complete their pregnancies and get healthy babies and there are more and more successful cases. I will share a few of the cases and my experience in treating miscarriage with Chinese herbal medicine and acupuncture
A 58-year-old woman presented with a 2-month history of intermittent epigastric pain. Her symptoms progressed to include pain radiating to the back and relief from sitting forward. Despite worsening pain, she went on a planned holiday trip where her husband noticed her eyes and urine had become yellow. On return, she was found to have abnormal liver enzymes and hyperbilirubinemia. She was diagnosed with obstructive jaundice likely due to pancreatic cancer. Patients who undergo pancreatic surgery are at risk for diabetes due to removal of part of the pancreas.
This case presentation discusses a 70-year-old male patient admitted with giddiness and generalized weakness for 15 days. After examination and investigations, he was diagnosed with acute idiopathic parkinsonism and type 2 diabetes mellitus. He was treated with levodopa, carbodopa, pramipexole, insulin, and lifestyle modifications. His symptoms improved over his 4 day hospital stay and he was discharged on medications with follow up in the neurology outpatient department.
For this Discussion, review the case Learning Resources and the DustiBuckner14
For this Discussion, review the case Learning Resources and the case study excerpt presented. Reflect on the case study excerpt and consider the therapy approaches you might take to assess, diagnose, and treat the patient’s health needs.
Case: An elderly widow who just lost her spouse.
Subjective: A patient presents to your primary care office today with chief complaint of insomnia. Patient is 75 YO with PMH of DM, HTN, and MDD. Her husband of 41 years passed away 10 months ago. Since then, she states her depression has gotten worse as well as her sleep habits. The patient has no previous history of depression prior to her husband’s death. She is awake, alert, and oriented x3. Patient normally sees PCP once or twice a year. Patient denies any suicidal ideations. Patient arrived at the office today by private vehicle. Patient currently takes the following medications:
•
Metformin 500mg BID
•
Januvia 100mg daily
•
Losartan 100mg daily
•
HCTZ 25mg daily
•
Sertraline 100mg daily
Current weight: 88 kg
Current height: 64 inches
Temp: 98.6 degrees F
BP: 132/86
By Day 3 of Week 7
Post
a response to each of the following:
• List three questions you might ask the patient if she were in your office. Provide a rationale for why you might ask these questions.
• Identify people in the patient’s life you would need to speak to or get feedback from to further assess the patient’s situation. Include specific questions you might ask these people and why.
• Explain what, if any, physical exams, and diagnostic tests would be appropriate for the patient and how the results would be used.
• List a differential diagnosis for the patient. Identify the one that you think is most likely and explain why.
• List two pharmacologic agents and their dosing that would be appropriate for the patient’s antidepressant therapy based on pharmacokinetics and pharmacodynamics. From a mechanism of action perspective, provide a rationale for why you might choose one agent over the other.
• For the drug therapy you select, identify any contraindications to use or alterations in dosing that may need to be considered based on the client’s ethnicity. Discuss why the contraindication/alteration you identify exists. That is, what would be problematic with the use of this drug in individuals of other ethnicities?
• Include any “check points” (i.e., follow-up data at Week 4, 8, 12, etc.), and indicate any therapeutic changes that you might make based on possible outcomes that may happen given your treatment options chosen.
Respond to the these discussions. All questions need to be addressed.
Discussion 1 En
Three questions to ask the patient and a rationale for asking these questions.
How may I be of assistance today? This question creates a rapport between you and the patients, and it makes her know that the doctor is ready to listen and help her.
What are you doing to cope with grief after losing your husband? This question will help the care ...
Examine Case Study Pakistani Woman with Delusional Thought Processe.docxcravennichole326
Examine Case Study: Pakistani Woman with Delusional Thought Processes.
You will be asked to make three decisions concerning the medication to prescribe to this client. Be sure to consider factors that might impact the client’s pharmacokinetic and pharmacodynamic processes.
At each decision point stop to complete the following:
Decision #1
Which decision did you select?
Why did you select this decision? Support your response with evidence and references to the Learning Resources.
What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources.
Explain any difference between what you expected to achieve with Decision #1 and the results of the decision. Why were they different?
Decision #2
Why did you select this decision? Support your response with evidence and references to the Learning Resources.
What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources.
Explain any difference between what you expected to achieve with Decision #2 and the results of the decision. Why were they different?
Decision #3
Why did you select this decision? Support your response with evidence and references to the Learning Resources.
What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources.
Explain any difference between what you expected to achieve with Decision #3 and the results of the decision. Why were they different?
Also include how ethical considerations might impact your treatment plan and communication with clients.
BACKGROUND
The client is a 34-year-old Pakistani female who moved to the United States in her late teens/early 20s. She is currently in an “arranged” marriage (her husband was selected for her since she was 9 years old). She presents to your office today following a 21 day hospitalization for what was diagnosed as “brief psychotic disorder.” She was given this diagnosis as her symptoms have persisted for less than 1 month.
Prior to admission, she was reporting visions of Allah, and over the course of a week, she believed that she was the prophet Mohammad. She believed that she would deliver the world from sin. Her husband became concerned about her behavior to the point that he was afraid of leaving their 4 children with her. One evening, she was “out of control” which resulted in his calling the police and her subsequent admission to an inpatient psych unit.
During today’s assessment, she appears quite calm, and insists that the entire incident was “blown out of proportion.” She denies that she believed herself to be the prophet Mohammad and states that her husband was just out to get her because he never loved her and wanted an “American wife” instead of her. She tells you that she knows this because the television is telling her so.
She currently weighs .
The document discusses various methods of administering medical cannabis for cancer patients including inhalation, ingestion, and topical application. It notes the time of onset and duration of effects for each method. The document also provides an overview of the endocannabinoid system and how cannabis may help certain cancer symptoms like pain, appetite issues, and nausea. It outlines some promising areas of preclinical research on cannabinoids treating different types of cancer. Potential side effects of cannabis are also mentioned.
This document provides guidance on deprescribing benzodiazepine receptor agonists (BZRAs) used to treat insomnia. It recommends non-drug approaches like cognitive behavioral therapy (CBT) as first-line treatment for insomnia. For patients taking BZRAs, it outlines a gradual tapering process to minimize withdrawal symptoms. Tapering should be individualized and involve both patient education and behavioral strategies to manage insomnia without medications.
This document discusses two case studies about prescribing analgesics for pain management.
In the first case study, a 35-year old man had hemorrhoid surgery and was initially prescribed paracetamol and celecoxib, but still reported a pain score of 7/10 after 4 hours.
The second case study describes an 81-year old woman with hip fracture reporting an 8/10 pain score. She has various medical conditions including hypertension, coronary artery disease, and diabetes.
The document prompts the reader to consider what additional analgesics they would prescribe for each case, taking into account factors like the patients' medical histories and reported pain levels.
The document discusses 10 medical conditions that may be helped by cannabis: epilepsy, chronic pain, fibromyalgia, post-traumatic stress disorder, multiple sclerosis, migraines, Crohn's disease, glaucoma/iritis, cancer, and Parkinson's disease. For each condition, it provides brief examples or studies that indicate cannabis may effectively treat symptoms, reduce pain, lower seizure activity, combat nausea, and more. The conclusion urges readers to share the information and advocate for legalizing medical cannabis.
This document summarizes the clinical uses of the antipsychotic drug quetiapine. It discusses quetiapine's approval for treating schizophrenia, bipolar disorder, depression, and other off-label uses. Key points include quetiapine being the first-line treatment for bipolar depression, its efficacy in reducing symptoms of schizophrenia and mania, and dosage guidelines for different conditions. Recent studies are cited showing quetiapine's benefits for outcomes in schizophrenia and improvements in working memory compared to other antipsychotics.
Quetiapine (brand name Seroquel) is an antipsychotic medication used to treat schizophrenia, bipolar disorder, depression, and other mental health conditions. It works by affecting dopamine and serotonin levels in the brain. Generic versions have been found to be equivalent to the brand name when rated by the FDA. Common side effects include drowsiness, dizziness, and dry mouth. It is important to take quetiapine as prescribed by your doctor and notify them immediately of any severe side effects. Community support workers should follow care plans, monitor for side effects, and ensure clients stay hydrated when taking quetiapine.
This document provides a guide for managing common symptoms in seriously ill pediatric patients, with a focus on end-of-life care. It outlines the social and medical aspects of accepting palliative care over curative treatment, maintaining comfort through active medical care, and managing a home or hospital death. The document also provides guidance on treating pain, nausea, anxiety, and other symptoms through pharmacological and non-pharmacological means.
This document provides an overview of managing pain in patients with or at risk for substance use disorders. It discusses the overlap between chronic pain and addiction, differentiating between types of pain and substance use disorders. It outlines goals of treatment as reducing suffering while eliminating unnecessary medication dependence. The document provides guidance on assessing patients' risk level and appropriately selecting and monitoring pain medications, with an emphasis on non-opioid options for high-risk patients. It also stresses the importance of addressing underlying mental health and social factors contributing to a patient's pain and addiction.
Premenstrual Syndrome – Recent Guidelines
Premenstrual Syndrome & Premenstrual Dysphoric Disorder
Incidence
80% of women have atleast one physical or psychiatric symptom during luteal phase
PMS -12-15%
PMDD – 1.3-5.3%
Quetiapine is a first-line atypical antipsychotic that has been used since 1998 for schizophrenia, bipolar disorder, depression, and other conditions. It is absorbed quickly in the body and metabolized in the liver. Quetiapine acts as an antagonist at serotonin, histamine, alpha-1, and dopamine receptors, with varying degrees of affinity. Common side effects include sedation, dizziness, hypotension, weight gain, and metabolic changes. Overdoses may cause lethargy, tachycardia, respiratory issues, and other symptoms, but are typically not fatal.
Second generation atypical anti-psychotic used for mental disorders more extensively for bipolar disorder. have very low side effects than other SGA Medications
Benefits of marijuana cannabis to chemotherapy (thesis)Daniel Bragais
This document discusses the benefits of marijuana for chemotherapy patients. It provides background on marijuana and its properties. Key points include:
- Marijuana contains THC which can help reduce nausea and vomiting from chemotherapy as well as ease other side effects.
- A case study is described of a woman named Leela whose health improved dramatically after being treated with cannabis oil for her cancer.
- The interviewee believes legalizing and regulating marijuana could help many cancer patients and create new jobs. However, some doctors remain skeptical due to cognitive biases and existing beliefs about pharmaceutical treatments.
Quetiapine in Clinical Neurological PracticeDr Tarek Asaad
Quetiapine XR provides advantages over the immediate release formulation for patients and clinicians. It allows for once-daily dosing, simplifies titration, and facilitates reaching therapeutic doses earlier through an initial higher dose. This makes adherence more likely. Studies also found Quetiapine XR had a better tolerability profile with less sedation and orthostatic hypotension compared to the immediate release formulation. Quetiapine more broadly has benefits for treating depression, psychosis, and behavioral symptoms associated with various neurological conditions due its antidepressant, antipsychotic, and sleep promoting effects with a low risk of side effects.
Generic Quetiapine Fumarate tablets (Qutipin) contain the active ingredient Quetiapine Fumarate. They are used to treat schizophrenia and bipolar disorder. They are manufactured by Sun Pharmaceutical Industries Ltd. and are available in strengths of 25 mg, 50 mg, 100 mg, 200 mg, and 300 mg. Qutipin is used for the treatment of schizophrenia as well as acute manic episodes and maintenance treatment of bipolar I disorder.
Premenstrual syndrome, or PMS, is a group of symptoms that start one to two weeks before your period. Most women have at least some symptoms of PMS, and the symptoms go away after their periods start. For some women, the symptoms are severe enough to interfere with their lives. They have a type of PMS called premenstrual dysphoric disorder, or PMDD.
Cannabis in India - HempCann owns the brand VEDI and is Manufacturer and Marketer of an excellent quality array of Ayurvedic, Herbals, Cannabis Medicine & Cannabis Oil and Castile Soap - Once you use a VEDI castile soap, no other soap will do.
https://vediherbals.com/
Cannabis in India - HempCann owns the brand VEDI and is Manufacturer and Marketer of an excellent quality array of Ayurvedic, Herbals, Cannabis Medicine & Cannabis Oil and Castile Soap - Once you use a VEDI castile soap, no other soap will do. https://vediherbals.com/
Crimson Publishers- Protecting Embryo with Chinese Herbal Medicine for Treati...CrimsonPublishers-PRM
It is almost impossible to protect the embryo, ladies successfully complete pregnancy, and have healthy babies, if they are going through vaginal bleeding, abdominal cramp and showing some other signs at the early month of pregnancy, which will normally end in miscarriages before TCM enters the West. Since the beginning of my practice of TCM (Acupuncture and Chinese herbal medicine) in UK, I have been using TCM for protecting embryo and terminating signs of miscarriage effectively in order to help ladies naturally complete their pregnancies and get healthy babies and there are more and more successful cases. I will share a few of the cases and my experience in treating miscarriage with Chinese herbal medicine and acupuncture
A 58-year-old woman presented with a 2-month history of intermittent epigastric pain. Her symptoms progressed to include pain radiating to the back and relief from sitting forward. Despite worsening pain, she went on a planned holiday trip where her husband noticed her eyes and urine had become yellow. On return, she was found to have abnormal liver enzymes and hyperbilirubinemia. She was diagnosed with obstructive jaundice likely due to pancreatic cancer. Patients who undergo pancreatic surgery are at risk for diabetes due to removal of part of the pancreas.
This case presentation discusses a 70-year-old male patient admitted with giddiness and generalized weakness for 15 days. After examination and investigations, he was diagnosed with acute idiopathic parkinsonism and type 2 diabetes mellitus. He was treated with levodopa, carbodopa, pramipexole, insulin, and lifestyle modifications. His symptoms improved over his 4 day hospital stay and he was discharged on medications with follow up in the neurology outpatient department.
For this Discussion, review the case Learning Resources and the DustiBuckner14
For this Discussion, review the case Learning Resources and the case study excerpt presented. Reflect on the case study excerpt and consider the therapy approaches you might take to assess, diagnose, and treat the patient’s health needs.
Case: An elderly widow who just lost her spouse.
Subjective: A patient presents to your primary care office today with chief complaint of insomnia. Patient is 75 YO with PMH of DM, HTN, and MDD. Her husband of 41 years passed away 10 months ago. Since then, she states her depression has gotten worse as well as her sleep habits. The patient has no previous history of depression prior to her husband’s death. She is awake, alert, and oriented x3. Patient normally sees PCP once or twice a year. Patient denies any suicidal ideations. Patient arrived at the office today by private vehicle. Patient currently takes the following medications:
•
Metformin 500mg BID
•
Januvia 100mg daily
•
Losartan 100mg daily
•
HCTZ 25mg daily
•
Sertraline 100mg daily
Current weight: 88 kg
Current height: 64 inches
Temp: 98.6 degrees F
BP: 132/86
By Day 3 of Week 7
Post
a response to each of the following:
• List three questions you might ask the patient if she were in your office. Provide a rationale for why you might ask these questions.
• Identify people in the patient’s life you would need to speak to or get feedback from to further assess the patient’s situation. Include specific questions you might ask these people and why.
• Explain what, if any, physical exams, and diagnostic tests would be appropriate for the patient and how the results would be used.
• List a differential diagnosis for the patient. Identify the one that you think is most likely and explain why.
• List two pharmacologic agents and their dosing that would be appropriate for the patient’s antidepressant therapy based on pharmacokinetics and pharmacodynamics. From a mechanism of action perspective, provide a rationale for why you might choose one agent over the other.
• For the drug therapy you select, identify any contraindications to use or alterations in dosing that may need to be considered based on the client’s ethnicity. Discuss why the contraindication/alteration you identify exists. That is, what would be problematic with the use of this drug in individuals of other ethnicities?
• Include any “check points” (i.e., follow-up data at Week 4, 8, 12, etc.), and indicate any therapeutic changes that you might make based on possible outcomes that may happen given your treatment options chosen.
Respond to the these discussions. All questions need to be addressed.
Discussion 1 En
Three questions to ask the patient and a rationale for asking these questions.
How may I be of assistance today? This question creates a rapport between you and the patients, and it makes her know that the doctor is ready to listen and help her.
What are you doing to cope with grief after losing your husband? This question will help the care ...
Examine Case Study Pakistani Woman with Delusional Thought Processe.docxcravennichole326
Examine Case Study: Pakistani Woman with Delusional Thought Processes.
You will be asked to make three decisions concerning the medication to prescribe to this client. Be sure to consider factors that might impact the client’s pharmacokinetic and pharmacodynamic processes.
At each decision point stop to complete the following:
Decision #1
Which decision did you select?
Why did you select this decision? Support your response with evidence and references to the Learning Resources.
What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources.
Explain any difference between what you expected to achieve with Decision #1 and the results of the decision. Why were they different?
Decision #2
Why did you select this decision? Support your response with evidence and references to the Learning Resources.
What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources.
Explain any difference between what you expected to achieve with Decision #2 and the results of the decision. Why were they different?
Decision #3
Why did you select this decision? Support your response with evidence and references to the Learning Resources.
What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources.
Explain any difference between what you expected to achieve with Decision #3 and the results of the decision. Why were they different?
Also include how ethical considerations might impact your treatment plan and communication with clients.
BACKGROUND
The client is a 34-year-old Pakistani female who moved to the United States in her late teens/early 20s. She is currently in an “arranged” marriage (her husband was selected for her since she was 9 years old). She presents to your office today following a 21 day hospitalization for what was diagnosed as “brief psychotic disorder.” She was given this diagnosis as her symptoms have persisted for less than 1 month.
Prior to admission, she was reporting visions of Allah, and over the course of a week, she believed that she was the prophet Mohammad. She believed that she would deliver the world from sin. Her husband became concerned about her behavior to the point that he was afraid of leaving their 4 children with her. One evening, she was “out of control” which resulted in his calling the police and her subsequent admission to an inpatient psych unit.
During today’s assessment, she appears quite calm, and insists that the entire incident was “blown out of proportion.” She denies that she believed herself to be the prophet Mohammad and states that her husband was just out to get her because he never loved her and wanted an “American wife” instead of her. She tells you that she knows this because the television is telling her so.
She currently weighs .
Delusional DisordersPakistani Female with Delusional Thought ProLinaCovington707
Delusional Disorders
Pakistani Female with Delusional Thought Processes
BACKGROUND
The client is a 34-year-old Pakistani female who moved to the United States in her late teens/early 20s. She is currently in an “arranged” marriage (her husband was selected for her when she was 9 years old). She presents following a 21-day hospitalization for what was diagnosed as “brief psychotic disorder.” She was given this diagnosis as her symptoms have persisted for less than 1 month.
Prior to admission, she was reporting visions of Allah, and over the course of a week, she believed that she was the prophet Mohammad. She believed that she would deliver the world from sin. Her husband became concerned about her behavior to the point that he was afraid of leaving their 4 children with her. One evening, she was “out of control,” which resulted in his calling the police and her subsequent admission to an inpatient psych unit.
During today’s assessment, she appears quite calm and insists that the entire incident was “blown out of proportion.” She denies that she believed herself to be the prophet Mohammad and states that her husband was just out to get her because he never loved her and wanted an “American wife” instead of her. She says she knows this because the television is telling her so.
She currently weighs 140 lbs., and she is 5’ 5.
SUBJECTIVE
Client reports that her mood is “good.” She denies auditory/visual hallucinations but believes that the television talks to her. She believes that Allah sends her messages through the TV. At times throughout the clinical interview, she becomes hostile towards you but then calms down.
A review of her hospital records shows that she received a medical workup from a physician, who reported her to be in overall good health. Lab studies were all within normal limits.
Client admits that she was tolerating her Risperdal well but stopped taking about a week after she got out of the hospital because she thinks her husband is going to poison her so that he can marry an American woman.
MENTAL STATUS EXAM
The client is alert and oriented to person, place, time, and event. She is dressed appropriately for the weather and time of year. She demonstrates no noteworthy mannerisms, gestures, or tics. Her speech is slow and, at times, interrupted by periods of silence. Self-reported mood is euthymic. Affect is constricted. Although the client denies visual or auditory hallucinations, she appears to be “listening” to something. Delusional and paranoid thought processes as described above. Insight and judgment are impaired. She is currently denying suicidal or homicidal ideation.
You administer the PANSS which reveals the following scores:
-40 for the positive symptoms scale
-20 for the negative symptom scale
-60 for general psychopathology scale
Diagnosis: Schizophrenia, paranoid type
RESOURCES
PANSS Scale. Available at: http://egret.psychol.cam.ac.uk/medicine/scales/PANSS
§ Kay, S. R., Fiszbein, A., & Opler, L. A. (1987). The Po ...
Safe Prescribing of Second Line Combined Oral Contraceptivemeducationdotnet
Here is what I would do next:
1. Perform a urine pregnancy test
2. Send for STI screening (chlamydia, gonorrhoea)
3. Consider pelvic ultrasound to check for ectopic pregnancy
4. Discuss options for changing contraception with the patient once investigations are complete
5. Review in 1 week with results of tests
6. Consider referral to gynaecology if pregnancy or infection is detected
The differential diagnosis includes:
- Ectopic pregnancy
- Intrauterine pregnancy
- Pelvic inflammatory disease
- Cervical infection
- Endometrial pathology
- Bleeding disorder
So in summary - investigate for pregnancy and infection, discuss
PharmaCon2007 Congress, Dubrovnik, Croatia "New Technologies and Trends in Pharmacy, Pharmaceutical Industry and Education" http://www.pharmacon2007.com
Abstract is available at http://www.pharmaconnectme.com
Running head HEALTH HISTORY AND PHYSICAL ASSESSMENT 1Heal.docxjeanettehully
Running head: HEALTH HISTORY AND PHYSICAL ASSESSMENT 1
Health History and Physical Assessment
Hannah Gabon
Chamberlain College of Nursing
NR304 Health Assessment II
Professor Christa Stigler
August 2019
Hannah Gabon
Hannah Gabon
Hannah Gabon
Health History Assessment and Physical Assessment 2
Health History Assessment and Physical Assessment
I conducted a health assessment on a 70 year’s old male patient from California who was
suffering from hypertension. The patient is currently taking diuretics medication which cause
increase urination. The medication also causes his sodium and fluids levels to drop thus lowering
patient’s blood pressure so it’s imperative to balance and monitor vital sign. The patient stated
that he was moderately satisfied with the care received in the facility. The patient is a smoker and
stated his concern of experiencing vision issues and heart failure, which prompted immediate
care for this patient.
Before being admitted to the hospital, patient stated that he was experiencing chest pain
which was not ending nor was it increasing in exertion. He did not experience nausea, vomiting,
dizziness or unconsciousness. He took some pain killers with no relief but managed to sleep in
the morning. After beginning his daily activities, the pain increased and was then rushed to the
hospital. He underwent some test that clarified that he was suffering from hypertension. When I
reviewed patient past medical records, it showed that he has condition at early age and minor
surgery. I reviewed the patient's cardiovascular, eyes, nose, throat, respiratory system, and his
immune system. Patient immunization was also put into consideration when I reviewed his past
medical record as this will be helpful planning for his care.
Thirty years ago, the patient developed a diffuse rash after he was injected with penicillin
which he was allergic to, but it was not known. Some of his past health operations includes:
chest pains in 1990 and minor surgery on his left arm. He has a medical case of pneumonia at an
early age, which did not take long to heal. The patient was raised by his stepmother since his
mother passed away 72 years ago from heart failure. His father passed on 68 years ago after
committing suicide in his house. His wife died 10 years ago after struggling with tuberculosis for
Hannah Gabon
98440000000099648
what condition?
Health History Assessment and Physical Assessment 3
a long period of time. He has six children; two are deceased after both suffered from
hypertension. He has 20 grandchildren and 10 great-grandchildren. His family have history of
hypertension but no known history of tuberculosis.
The patient’s physical assessment findings were that he had an elevated blood pressure of
125/80 which shows that it was high, but it is controllable. I also found that he had a unique heart
sound which was as a result of an enlarged heart. The patient had a swoll ...
Melissa Hinkhouse
Advanced Pharmacology NURS-6521N-43
Professor Dr. Vicki Gardin
Discussion Board Week 1-Original Post
11/30/2020
I have worked in an outpatient behavioral health clinic for the past seven years with many different providers. I live in a rural community, many patients wait six to twelve months to be seen. Patients being treated for Attention Deficit Disorder must be officially tested before being seen by a Psychologist. For this discussion board post, I have changed the name of my patient to Paul to ensure patient confidentially. The provider I worked with this particular patient will also be referred to as PMHNP to ensure provider confidentiality.
Paul was a ten-year-old Caucasian male referred to our clinic diagnosed per DSM criteria, confirmed via Psychologist testing with ADHD. When he saw the Psychologist, he was also diagnosed with mild depression and anxiety. He struggled with concentration, hyperactivity, impulse control, and disorganization. He presented to his appointment with his mother and father, clean, well-nourished, pleasant, interactive with staff, reported no medication allergies, current medication Zyrtec for seasonal allergies. Paul just had his well-child exam and is current on vaccinations and his primary care provider completed lab work to include CBC, CMP, TSH, Vit D, B12, and A1C, all have returned normal. Family history reported father has a history of ADHD (never medicated), brother has a history of depression and anxiety (never medicated treating with psychotherapy), no other significant family history to report. Paul’s current weight at his appointment was 30kg.
PMHNP spent one hour with Paul and his parents for the initial new patient appointment (Thursday). It was decided Paul would be prescribed Strattera (atomoxetine) 40mg once a day for one week then increase to 80mg once a day. I returned to work on Monday and received a call from Paul’s mom, she said he was acting strange. He was tearful, had been in his room with the door closed for most of the weekend, she stated on Sunday she went into his room and he was crying and said he was just thinking about dying and his parents dying. She stated he had already had his meds Sunday so she kept him with her that entire day and made Sunday night a campout night in the Livingroom so he would think it was fun and she could keep a close eye on him. I had a cancelation that morning for him to come to see PMHNP and he was in to see her within twenty minutes and removed from Strattera. His parents decided medications were no longer the route they wanted to try for treatment and a referral was made for psychotherapy.
The only medication Paul takes on occasion is Zyrtec which is in an antihistamine drug class, Strattera is a selective norepinephrine reuptake inhibitor; there is no known drug interaction between the two medications. Reflecting on his age and the medication, Strattera has a black box labeled for suicidal ideation with adolescents dia.
The document provides information on conducting a patient medication history interview. It defines medication history as detailed information on all prescribed and non-prescribed medications a patient is currently taking or has taken. The goals of an interview are to gather complete medication information to identify discrepancies, document allergies, and assess medication compliance and interactions. Key steps include confirming patient identity, explaining the purpose, and asking open-ended questions to collect accurate medication details including name, dose, frequency, and reasons for use.
The patient is a 21-year-old female who presented with vaginal discharge and odor for one week. Her history included a positive chlamydia test in January which was treated. On examination, she had scant white vaginal discharge. The differential diagnoses were acute chlamydia infection and vaginal discharge. The primary diagnosis was acute chlamydia based on her previous positive test. The plan was to test for chlamydia and treat based on results, with a follow up if needed.
Multiple sclerosis case scenario study basedtasbeehalibra
Case scenario of multiple sclerosis . Disease modification drugs. Ljermitte sign. Cerebellar sign. Uthoff phenomenon . Parkinsonism neurology neurosurgery. Cerebellar signs diseasSymptoms of MS vary from person to person and depend on the location and severity of nerve fibre damage. These often include vision problems, tiredness, trouble walking and keeping balance, and numbness or weakness in the arms and legs. Symptoms can come and go or last for a long time.
The causes of MS are not known but a family history of the disease may increase the risk.
While there is no cure for MS, treatment can reduce symptoms, prevent further relapses and improve quality of life.Disease course
Most people with MS have a relapsing-remitting disease course. They experience periods of new symptoms or relapses that develop over days or weeks and usually improve partially or completely. These relapses are followed by quiet periods of disease remission that can last months or even years.
Small increases in body temperature can temporarily worsen signs and symptoms of MS. These aren't considered true disease relapses but pseudorelapses.
At least 20% to 40% of those with relapsing-remitting MS can eventually develop a steady progression of symptoms, with or without periods of remission, within 10 to 20 years from disease onset. This is known as secondary-progressive MS.
The worsening of symptoms usuallyCauses
The cause of multiple sclerosis is unknown. It's considered an immune mediated disease in which the body's immune system attacks its own tissues. In the case of MS, this immune system malfunction destroys the fatty substance that coats and protects nerve fibers in the brain and spinal cord (myelin).
Myelin can be compared to the insulation coating on electrical wires. When the protective myelin is damaged and the nerve fiber is exposed, the messages that travel along that nerve fiber may be slowed or blocked.
It isn't clear why MS develops in some people and not others. A combination of genetics and environmental factors appears to be responsible.
Risk factors
These factors may increase your risk of developing multiple sclerosis:
Age. MS can occur at any age, but onset usually occurs around 20 and 40 years of age. However, younger and older people can be affected.
Sex. Women are more than 2 to 3 times as likely as men are to have relapsing-remitting MS.
Family history. If one of your parents or siblings has had MS, you are at higher risk of developing the disease.
Certain infections. A variety of viruses have been linked to MS, including Epstein-Barr, the virus that causes infectious mononucleosis.
Race. White people, particularly those of Northern European descent, are at highest risk of developing MS. People of Asian, African or Native American descent have the lowest risk. A recent study suggests that the number of Black and Hispanic young adults with multiple sclerosis may be greater than previously thought.
Climate. MS is far more common in countries wit
C. Give the patient Tylenol 650mg P.O as ordered and assist the patient with guided imagery.
This patient's pain level is relatively low at a 2/10 and is being well managed with scheduled Tylenol. Guided imagery could help further reduce the patient's perception of pain without unnecessary opioid exposure. Options A, B, and D would likely provide more pain relief than is needed and increase risks of opioid dependence, misuse or overdose.
1) Statins are drugs that lower cholesterol levels in the bloodstream and prevent its buildup in arteries, reducing the risk of cardiovascular diseases like heart attacks and strokes.
2) Statins work by inhibiting the liver's production of cholesterol and lowering the amount of cholesterol in the bloodstream. They are most effective when taken alongside a healthy, low-fat diet.
3) While statins can help reduce premature deaths from cardiovascular diseases, some argue they may encourage unhealthy eating habits. Potential side effects like liver damage and muscle problems are also a concern.
Case Based Panel Discussion on Menopausal healthSujoy Dasgupta
Dr Sujoy Dasgupta moderated a panel on "Case Based Panel Discussion on Menopausal health" in the CME on Menopausal Health, organized by the AICC RCOG (All India Coordinating Committee) East Zone, held in Kolkata in March, 2022
ntroduction to the case (1 page)Briefly explain and summarize .docxdunhamadell
ntroduction to the case (1 page)
Briefly explain and summarize the case for this Assignment. Be sure to include the specific patient factors that may impact your decision making when prescribing medication for this patient.
Decision #1 (1 page)
Which decision did you select?
Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature).
Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples.
Decision #2 (1 page)
Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature).
Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples.
Decision #3 (1 page)
Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature).
Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples.
Conclusion (1 page)
Summarize your recommendations on the treatment options you selected for this patient. Be sure to justify your recommendations and support your response with clinically relevant and patient-specific resources, including the primary literature.
Decision Point One
Start Zyprexa (olanzapine) 10 mg orally at BEDTIME
RESULTS OF DECISION POINT ONE
·
Client returns to clinic in four weeks
·
Her PANSS decreases to a partial response (decrease in positive symptoms by 25%)
·
She comes in today with a reported weight gain of 5 pounds. When questioned further on this point, she states that she can never seem to get f.
This document discusses mood disorders, specifically depression. It provides the DSM-IV criteria for a major depressive episode, including symptoms such as depressed mood, diminished interest, changes in appetite, insomnia, fatigue, feelings of worthlessness, difficulty concentrating, and suicidal thoughts. It also discusses treatment options, focusing on pharmacotherapy. SSRIs are considered a first-line treatment and details are provided about specific SSRIs, their mechanisms of action, indications, and precautions. Risk factors for suicide are briefly covered.
S.N. is a 15-year-old female who was brought to a facility by her uncle for evaluation of bipolar disorder type 1. She has a history of risky behaviors like substance use and unsafe sexual encounters. Her current medications are not effective and she is non-compliant. The treatment plan aims to simplify her medication regimen to improve compliance and provide psychotherapy and education to support her safety, well-being and recovery.
1. The document describes several patient cases involving medication management and nursing care. Details are provided about the patients' conditions, medical histories, vital signs, lab results, treatments and nursing assessments.
2. Nurses are asked to answer questions for each case related to diagnoses, monitoring, patient education and medication management.
3. Lab results, provider orders and treatment plans are still pending or in progress for some of the patients.
Similar to NR 508 Enhance teaching - snaptutorial.com (18)
Walmart Business+ and Spark Good for Nonprofits.pdfTechSoup
"Learn about all the ways Walmart supports nonprofit organizations.
You will hear from Liz Willett, the Head of Nonprofits, and hear about what Walmart is doing to help nonprofits, including Walmart Business and Spark Good. Walmart Business+ is a new offer for nonprofits that offers discounts and also streamlines nonprofits order and expense tracking, saving time and money.
The webinar may also give some examples on how nonprofits can best leverage Walmart Business+.
The event will cover the following::
Walmart Business + (https://business.walmart.com/plus) is a new shopping experience for nonprofits, schools, and local business customers that connects an exclusive online shopping experience to stores. Benefits include free delivery and shipping, a 'Spend Analytics” feature, special discounts, deals and tax-exempt shopping.
Special TechSoup offer for a free 180 days membership, and up to $150 in discounts on eligible orders.
Spark Good (walmart.com/sparkgood) is a charitable platform that enables nonprofits to receive donations directly from customers and associates.
Answers about how you can do more with Walmart!"
How to Make a Field Mandatory in Odoo 17Celine George
In Odoo, making a field required can be done through both Python code and XML views. When you set the required attribute to True in Python code, it makes the field required across all views where it's used. Conversely, when you set the required attribute in XML views, it makes the field required only in the context of that particular view.
Main Java[All of the Base Concepts}.docxadhitya5119
This is part 1 of my Java Learning Journey. This Contains Custom methods, classes, constructors, packages, multithreading , try- catch block, finally block and more.
How to Fix the Import Error in the Odoo 17Celine George
An import error occurs when a program fails to import a module or library, disrupting its execution. In languages like Python, this issue arises when the specified module cannot be found or accessed, hindering the program's functionality. Resolving import errors is crucial for maintaining smooth software operation and uninterrupted development processes.
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...PECB
Denis is a dynamic and results-driven Chief Information Officer (CIO) with a distinguished career spanning information systems analysis and technical project management. With a proven track record of spearheading the design and delivery of cutting-edge Information Management solutions, he has consistently elevated business operations, streamlined reporting functions, and maximized process efficiency.
Certified as an ISO/IEC 27001: Information Security Management Systems (ISMS) Lead Implementer, Data Protection Officer, and Cyber Risks Analyst, Denis brings a heightened focus on data security, privacy, and cyber resilience to every endeavor.
His expertise extends across a diverse spectrum of reporting, database, and web development applications, underpinned by an exceptional grasp of data storage and virtualization technologies. His proficiency in application testing, database administration, and data cleansing ensures seamless execution of complex projects.
What sets Denis apart is his comprehensive understanding of Business and Systems Analysis technologies, honed through involvement in all phases of the Software Development Lifecycle (SDLC). From meticulous requirements gathering to precise analysis, innovative design, rigorous development, thorough testing, and successful implementation, he has consistently delivered exceptional results.
Throughout his career, he has taken on multifaceted roles, from leading technical project management teams to owning solutions that drive operational excellence. His conscientious and proactive approach is unwavering, whether he is working independently or collaboratively within a team. His ability to connect with colleagues on a personal level underscores his commitment to fostering a harmonious and productive workplace environment.
Date: May 29, 2024
Tags: Information Security, ISO/IEC 27001, ISO/IEC 42001, Artificial Intelligence, GDPR
-------------------------------------------------------------------------------
Find out more about ISO training and certification services
Training: ISO/IEC 27001 Information Security Management System - EN | PECB
ISO/IEC 42001 Artificial Intelligence Management System - EN | PECB
General Data Protection Regulation (GDPR) - Training Courses - EN | PECB
Webinars: https://pecb.com/webinars
Article: https://pecb.com/article
-------------------------------------------------------------------------------
For more information about PECB:
Website: https://pecb.com/
LinkedIn: https://www.linkedin.com/company/pecb/
Facebook: https://www.facebook.com/PECBInternational/
Slideshare: http://www.slideshare.net/PECBCERTIFICATION
How to Build a Module in Odoo 17 Using the Scaffold MethodCeline George
Odoo provides an option for creating a module by using a single line command. By using this command the user can make a whole structure of a module. It is very easy for a beginner to make a module. There is no need to make each file manually. This slide will show how to create a module using the scaffold method.
বাংলাদেশের অর্থনৈতিক সমীক্ষা ২০২৪ [Bangladesh Economic Review 2024 Bangla.pdf] কম্পিউটার , ট্যাব ও স্মার্ট ফোন ভার্সন সহ সম্পূর্ণ বাংলা ই-বুক বা pdf বই " সুচিপত্র ...বুকমার্ক মেনু 🔖 ও হাইপার লিংক মেনু 📝👆 যুক্ত ..
আমাদের সবার জন্য খুব খুব গুরুত্বপূর্ণ একটি বই ..বিসিএস, ব্যাংক, ইউনিভার্সিটি ভর্তি ও যে কোন প্রতিযোগিতা মূলক পরীক্ষার জন্য এর খুব ইম্পরট্যান্ট একটি বিষয় ...তাছাড়া বাংলাদেশের সাম্প্রতিক যে কোন ডাটা বা তথ্য এই বইতে পাবেন ...
তাই একজন নাগরিক হিসাবে এই তথ্য গুলো আপনার জানা প্রয়োজন ...।
বিসিএস ও ব্যাংক এর লিখিত পরীক্ষা ...+এছাড়া মাধ্যমিক ও উচ্চমাধ্যমিকের স্টুডেন্টদের জন্য অনেক কাজে আসবে ...
How to Setup Warehouse & Location in Odoo 17 InventoryCeline George
In this slide, we'll explore how to set up warehouses and locations in Odoo 17 Inventory. This will help us manage our stock effectively, track inventory levels, and streamline warehouse operations.
A review of the growth of the Israel Genealogy Research Association Database Collection for the last 12 months. Our collection is now passed the 3 million mark and still growing. See which archives have contributed the most. See the different types of records we have, and which years have had records added. You can also see what we have for the future.
Strategies for Effective Upskilling is a presentation by Chinwendu Peace in a Your Skill Boost Masterclass organisation by the Excellence Foundation for South Sudan on 08th and 09th June 2024 from 1 PM to 3 PM on each day.
Your Skill Boost Masterclass: Strategies for Effective Upskilling
NR 508 Enhance teaching - snaptutorial.com
1. NR 508 Week 1 Discussions
For more classes visit
www.snaptutorial.com
Discussion Part One
Emily, a relatively healthy 5’5”, 32-year-old young woman weighing
190 pounds, presents to your clinic with hirsutism, anovulation,
oligomenorrhea, and at times amenorrhea. Biochemical blood tests
reveal elevated luteinizing hormone (LH, without a mid-cycle surge) and
androgen elevation.
She mentions that she also has a family history of irregular cycles, and
that her grandmother experienced early menopause. She also states that
she is sexually active, occasionally smokes (1 pack/month), and desires
to be prescribed one medication to mitigate her symptoms, as well as,
prevent her from becoming pregnant.
Please provide a list of differential diagnoses, as well as an indication of
your primary diagnosis.
Once this has been completed, please indicate and describe your chosen
pharmacological treatment with inclusion of dose and mechanism of
action of your chosen prescription.
Discussion Part Two
You diagnose Emily with polycystic ovarian syndrome (PCOS) and
decide to prescribe drospirenone-ethinyl-estradiol as a way to control
both the PCOS symptoms, as well as to act as an oral contraceptive.
2. At what dose should this be prescribed?
What is the mechanism of drospirenone-ethinyl-estradiol, and why
would, because of its mechanism, it be a good choice for her PCOS
symptoms (Include the medication-altered physiology)?
How would you monitor for efficacy and toxicity?
At what dose should this be prescribed?
Discussion Part Three (graded)
Emily subsequently returns to your clinic 5 months later, and decides to
inform you that within the first 3 months after treatment, she struggled
with a severe bout of depression. Instead of returning to your clinic to be
prescribed, yet another pharmaceutical, she consulted her herbalist who
told her about the anti-depressant, over-the-counter, herbal formulation,
St. John’s Wort. She decided to begin taking St. John’s Wort in
conjunction with her prescribed oral contraceptive medication, and she
has now reappeared at your clinic because she is pregnant, and is
distraught about how this occurred since she took her oral contraceptive
compliantly since its prescription.
Why then, is she pregnant?
Please include detailed pharmacological mechanisms of how this
occurred, and your subsequent steps in her management.
**************************************
NR 508 Week 2 Discussions
For more classes visit
3. www.snaptutorial.com
Discussion Part One
Cynthia is a 65-year-old African American female who presents to the
clinic for a check-up. Her last examination was ~5 years ago. She has no
specific, significant, or urgent complaint. She explains that her only
issues are thirst, fatigue, and leg numbness and tingling, which is
beginning to occur more often. You decide to do a physical exam, as
well as draw labs and receive the following results:
Social history: no smoking or alcohol consumption.
Physical examination:
GEN: well nourished, slightly obese female
VS: BP 180/103 HR 73 RR 13 T 98.4 Weight 90 kg, Height 5’6”
HEENT: PERRLA
COR: RRR, NMRG
CHEST: CTA
NEURO: monofilament test shows decreased peripheral sensation
EXT: normal
Laboratory (fasting):
Na 139 mEq/L
K 3.8 mEq/L
ALT 34 U/L
Ca 9.1 mg/dL
CL 102 mmol/L
HCO3 22 mEq/L
AST 39 U/L
TP 6 g/dL
BUN 33 mg/dL
SCr 2.0 mg/dL
Alb 4.1 g/dL
4. Cholesterol 254 mg/dL
BG 300 mg/dL
TSH 0.12 mU/mL
UA: SG 1.013 mg/24h, pH 6.5, +++ protein
What are the major problems in this patient, and what diagnoses do these
values indicate?
Additionally, what is your assessment and pharmacological plan for
each of these problems including the medication, dose, and mechanism
of action?
Discussion Part Two (graded)
Cynthia has been prescribed a plethora of medications. How will you
properly monitor each medication for efficacy and toxicity? Are you
concerned with any drug-drug interactions? If so, what are they, and
what is the mechanism of the interaction?
Discussion Part Three (graded)
Given Cynthia’s increased creatinine and renal deterioration, metformin
is probably not optimal in this case. Therefore, upon subsequent visits,
you decide to start her on a sulfonylurea. She reappears in your clinic
fairly soon thereafter with complaints of shakiness, sweating, chills,
clamminess, lightheadedness, and a moderately severe headache.
• What is the diagnosis given these symptoms and the medications she is
currently taking from Parts One and Two, and how would you proceed?
• At this point, please also be sure to also provide an accurate summary
of Cynthia’s medication plan.
**************************************
5. NR 508 Week 3 Discussions
For more classes visit
www.snaptutorial.com
Discussion Part One
Elliot is a 74 year-old male who presents to your clinic with complaints
of frequent nosebleeds (4 in the past week) and several severe bruises
scattered variously throughout his anatomy. The patient is also
complaining of a runny nose, cough, and head/chest congestion. He has
a history of chronic atrial fibrillation and is currently prescribed and
taking warfarin. Approximately 3 weeks previously, he started taking
over-the-counter cimetidine for heartburn he was experiencing. Below
is a list of the patient’s medications, his physical examination, and his
laboratory findings:
Medications
Digoxin 0.25 mg QD Cimetidine OTC BID
Pseudoephedrine SR 120 BID Warfarin 7 mg QD
Allergies: NKDA
Physical Examination
VS: BP: 180/95, HR 75, irregularly irregular, RR 17
Weight: 95 kg
HEENT: WNL
ABD: + Bowel Sounds EXT: Bruising on arms and legs
6. NEURO: Alert & Oriented x 3 GEN: Well developed, well-nourished
male
ECG: atrial fibrillation
Laboratory
Na 143 mEq/L K 4.5 mEq/L
Cl 99 mmol/L CO2 25 mEq/L
BUN 18 mg/dL SCr 0.9 mg/dL
INR 4.8 Hct 42%
Hbg 15 mg/dL Digoxin 3.8 ng/ml
What problems should be identified in this patient?
What are the precise mechanisms of action of each drug?
What do you think is contributing to the patient’s hypertension?
Are there any drug interactions that you can identify as associated with
this current drug regimen, and if so how, mechanistically, are they
occurring?
What is the clinical significance of these interactions?
Discussion Part Two
You have decided to have him stop the pseudoephedrine related to his
hypertension, as well as the cimetidine related to its interaction with
warfarin. The patient returns for his monthly follow-up appointment, and
it is noticed that his blood pressure (195/80) has not come under control.
You decide to start him on hydrochlorothiazide.
Is there a better medication than a thiazide, and if so what dose should
you initiate this medication?
How would you proceed, and how you would monitor for efficacy and
toxicity?
Discussion Part Three
He returns a month later complaining of increased fatigue, visual
disturbances, weakness, and nausea; however, his ECG is normal.
7. Based on this information, what is occurring in this patient? Include
precise mechanism(s) of how it is occurring.
Additionally, please include any drug interactions associated with any
new medications initiated keeping in mind the current regimen.
**************************************
NR 508 Week 4 Discussions
For more classes visit
www.snaptutorial.com
Discussion Part One
Barbara is a married 39-year-old woman with no children, smokes 1
pack/day, and weighs 180 pounds who has scheduled an appointment
with you to discuss feelings of anhedonia that she has been experiencing
for the past few months. She has a history of depression as a teenager,
but has not needed or received therapy for ~20 years. At the
appointment, she relays that she has been experiencing chronic
fatigue/loss of energy, feelings of worthlessness, appetite disturbances,
weight gain, inability to concentrate, psychomotor disturbances, and
insomnia.
Please provide a list of differential diagnoses, as well as an indication of
your primary diagnosis.
8. Once this has been completed, please indicate and describe your chosen
pharmacological treatment with inclusion of dose and mechanism of
action of your chosen prescription.
Discussion Part Two (graded)
Monitoring for efficacy and toxicity of the current drug regimen you
prescribed in Part One
Subsequent steps if this patient did not have an adequate response?
Assume you had her on a common, selective serotonin reuptake inhibitor
for several months without great response. Explain why the SSRI should
be slowly discontinued prior to starting bupropion in Part Three.
Discussion Part Three
You decide to begin the patient on bupropion.
At what dose should she be started on bupropion, and how does
bupropion differ from other commonly prescribed antidepressants, such
as fluoxetine, venlafaxine, and nortriptyline?
Why would this be the best option for this patient given her symptoms
and lifestyle? In your answer, be sure to compare and contrast bupropion
with each medication mentioned above (fluoxetine, venlafaxine, and
nortriptyline).
**************************************
NR 508 Week 5 Discussions
9. For more classes visit
www.snaptutorial.com
Discussion Part One
Leroy is a 70 year-old-man, whose wife passed away 5 years ago, and
whose 2 children live out-of–state. His neighbor caretaker (Ms. Webb, a
middle-aged retired CNA, whom his children hired to provide home care
to him 3x/week) brings him to your clinic. He presents with quite severe
confusion, incidentally to very minor changes in his environment, which
provokes some violence (a symptom which startles Ms. Webb),
increasingly impaired judgment, and increasing repetitiousness and
inconsistencies in his usual behavior. Upon initial work-up and physical
exam, you notice an increased respiratory rate, a slight fever (100°F),
and cost vertebral angle tenderness on his right side.
Discussion Part Two (graded)
The patient is diagnosed with a severe urinary tract infection
(pyelonephritis), and you decide to prescribe him
sulfamethoxazole/trimethoprim (SMX/TMP) beginning with 2 g initially
as a loading dose, followed by 1 g as a maintenance dose BID. Over the
next couple of weeks, the symptoms associated with his UTI diminish,
and his mental status improves. However, Ms. Webb brings him back to
your clinic with symptoms, which scare her yet again, and she explains
that she thinks he may have a relapse of his UTI. These symptoms
include a high fever (103.6°F) and tachypnea, and upon pulmonary
examination at your clinic, you hear crackles, and find classic findings
of lung consolidation.
10. What laboratory tests should you order, and what is your primary
diagnosis at this point and subsequent steps in his treatment and
management?
Once explained, please indicate and describe your chosen
pharmacological treatment with inclusion of dose and mechanism of
action of your chosen prescription.
Discussion Part Three
Upon receipt of laboratory results, you notice that his eGFR is
~40mL/min, his serum creatinine is 3.0 mg/dl, and his BUN is 50 mg/dl.
How will the medication regimen(s) have to be adjusted given these new
laboratory findings, and how should you be monitoring for efficacy and
toxicity of this patient’s pharmacological profile with a summary of
where this patient currently stands in his medical treatment?
**************************************
NR 508 Week 6 Discussions
For more classes visit
www.snaptutorial.com
Discussion Part One
Jonathon is a 56 year-old retired automobile mechanic who has not been
to the doctor in approximately 6-7 years. He presents to your office
11. complaining that 3 weeks ago he was awoken with severe pain and
inflammation in his knee, which has been consistent since that initial
night. Upon physical examination of his knee, it appears swollen and
erythematous with periarticular involvement. Upon physical
examination and laboratory results you notice the following:
Physical examination:
GEN: well nourished, obese male (310 pounds)
VS: BP 191/112 HR 75 RR 15 T 98.6, HT 5’8”
EXT: Knee joint inflammation
Laboratory (fasting):
Na 139 mEq/L
K 3.8 mEq/L
Ca 9.1 mg/dL
CL 102 mmol/L
HCO3 22 mEq/L
BUN 10 mg/dL
SCr 0.9 mg/dL
Serum Uric Acid 6.5 mg/dL
Alb 4.1 g/dL
Cholesterol 300 mg/dL
UA: pH 6.8, uric acid 250 mg/24h
What problems can be identified in this patient? Please provide a list of
differential diagnoses, as well as indication of your primary diagnosis.
What is your pharmacological plan for your primary diagnosis including
the medication, dose, and mechanism of action?
Discussion Part Two (graded)
He returns to your clinic for follow-up blood work, and 4 values catch
your attention:
AST 430 U/L
ALT 535 U/L
12. Bilirubin 41 mg/dl
BG 60 mg/dl
He admits to a history of moderate-to-high alcohol intake (>12
drinks/week for >10 years). He is slightly febrile (99.7°F) and has
abdominal tenderness. He also admits to taking several, different over-
the-counter pain relievers of different brands daily and continuously to
combat the pain in his knee, in addition to his prescription(s) in Part
One. You decide to run a toxicology lab, and it reveals a blood
acetaminophen concentration of 58 µg/mL.
What is the diagnosis at this point in his case? Please explain the
mechanism for how this occurs/occurred, and the antidote’s mechanism
of action.
What is the subsequent management and treatment for this individual
related to the diagnosis in Part One.
Discussion Part Three (graded)
This is your third time seeing this patient, and he reports the NSAID that
he has been prescribed is not addressing his pain. He reports his pain is a
10 out of 10, HR 108, talking extremely fast, he is diaphoretic,
unshaved, his clothes are a bit wrinkled and he is requesting that you
prescribe him Percocet because he doesn’t think Tramadol, that you are
considering prescribing, will work.
What are the possible signs of prescription drug abuse?
What should the NP do when a patient has continued to return?
**************************************
NR 508 Week 7 Discussions
13. For more classes visit
www.snaptutorial.com
Discussion Part One
Adam is an active, healthy 5’10” 34 year-old man weighing 145 pounds.
He presents to your clinic with complaints of wheezing, dyspnea, cough,
and sputum production, especially when running. He informs you that he
is an avid marathon runner competing in one to two 5 or 10K runs per
month. He tells you that he is symptomatic more than 2 times per week,
but less that 1 times per day, and nighttime symptoms hardly ever occur.
He also adds that his symptoms can get worse after and sometimes
during his runs, especially when the outside temperature drops below
50°F.
Please provide a list of differential diagnoses, as well as indication of
your primary diagnosis.
What is your pharmacological plan for your primary diagnosis including
the medication, dose, and mechanism of action?
Discussion Part Two (graded)
Your patient returns to your office 4 weeks following his initial
appointment in Part one with only moderate reduction in symptomology
and an increase in nightly symptoms to 1 time per week. Upon closer
inspection of his medical records you notice that he has also been
prescribed metoprolol (25 mg/day extended release) for uncontrolled
familial hypertension.
What is the mechanism of action of metoprolol, and why is this an
important issue in this patient? Be sure to contrast the differences
between your prescribed/discussed medication in Parts One and the
14. metoprolol just discovered. Also, include your new patient plan with
medication changes and details of dose and mechanism of action.
Discussion Part Three (graded)
How would you monitor for efficacy and toxicity of the current drug
regimen you prescribed in Part One, and what would be your subsequent
steps if this patient did not have an adequate response?
**************************************